Industry Warns Of Cost-Shifting With Use Of Radiology Benefit Managers
This article was originally published in The Gray Sheet
As policymakers consider the cost-saving prospects of requiring imaging scans to be pre-authorized by radiology benefit managers for Medicare coverage, industry is arguing that the policy may simply shift costs to providers.
You may also be interested in...
The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.
Investors are closely following a Phase III study testing Wainua in ATTR cardiomyopathy, which could read out early in 2025.
Pulling the controversial Alzheimer’s drug’s BLA should not exempt Biogen from fulfilling ClinicalTrials.gov reporting requirements for two key studies, even if the research gets terminated, former head of the NIH data repository tells the Pink Sheet.